Proteolethargy is a pathogenic mechanism in chronic disease.

TitleProteolethargy is a pathogenic mechanism in chronic disease.
Publication TypeJournal Article
Year of Publication2025
AuthorsDall'Agnese A, Zheng MM, Moreno S, Platt JM, Hoang AT, Kannan D, Dall'Agnese G, Overholt KJ, Sagi I, Hannett NM, Erb H, Corradin O, Chakraborty AK, Lee TIhn, Young RA
JournalCell
Volume188
Issue1
Pagination207-221.e30
Date Published2025 Jan 09
ISSN1097-4172
KeywordsAnimals, Chronic Disease, Cysteine, Humans, Inflammation, Mice, Proteins, Reactive Oxygen Species, Signal Transduction
Abstract

The pathogenic mechanisms of many diseases are well understood at the molecular level, but there are prevalent syndromes associated with pathogenic signaling, such as diabetes and chronic inflammation, where our understanding is more limited. Here, we report that pathogenic signaling suppresses the mobility of a spectrum of proteins that play essential roles in cellular functions known to be dysregulated in these chronic diseases. The reduced protein mobility, which we call proteolethargy, was linked to cysteine residues in the affected proteins and signaling-related increases in excess reactive oxygen species. Diverse pathogenic stimuli, including hyperglycemia, dyslipidemia, and inflammation, produce similar reduced protein mobility phenotypes. We propose that proteolethargy is an overlooked cellular mechanism that may account for various pathogenic features of diverse chronic diseases.

DOI10.1016/j.cell.2024.10.051
Alternate JournalCell
PubMed ID39610243
PubMed Central IDPMC11724756
Grant ListKL2 TR002542 / TR / NCATS NIH HHS / United States
P01 CA155258 / CA / NCI NIH HHS / United States
R35 GM144283 / GM / NIGMS NIH HHS / United States